Rosa Apel

Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in IPF.

T. Derlin, A. Prasse, T. Welte, 2020, Chest.

Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011

Tobias Welte, T. Welte, Mathias W Pletz, 2013, BMC Infectious Diseases.

Quantification of dual-energy CT-derived functional parameters as potential imaging markers for progression of idiopathic pulmonary fibrosis

F. Wacker, A. Prasse, T. Welte, 2021, European Radiology.

High CXCL6 drives matrix expression and correlate with markers of poor outcome in IPF

J. Tedrow, A. Prasse, N. Kaminski, 2021, bioRxiv.